Literature DB >> 18182481

OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells.

Margaret A Park1, Adly Yacoub, Mohammed Rahmani, Guo Zhang, Lori Hart, Michael P Hagan, Stuart K Calderwood, Michael Y Sherman, Costas Koumenis, Sarah Spiegel, Ching-Shih Chen, Martin Graf, David T Curiel, Paul B Fisher, Steven Grant, Paul Dent.   

Abstract

We have further defined mechanism(s) by which 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}acetamide [OSU-03012 (OSU)], a derivative of the cyclooxygenase-2 (COX2) inhibitor celecoxib but lacking COX2 inhibitory activity, kills transformed cells. In cells lacking expression of protein kinase R-like endoplasmic reticulum kinase (PERK(-/-)), the lethality of OSU was attenuated. OSU enhanced the expression of Beclin 1 and ATG5 and cleavage of pro-caspase 4 in a PERK-dependent fashion and promoted the Beclin 1- and ATG5-dependent formation of vacuoles containing LC3, followed by a subsequent caspase 4-dependent cleavage of cathepsin B and a cathepsin B-dependent formation of low pH intracellular vesicles; cathepsin B was activated and released into the cytosol and genetic suppression of caspase 4, cathepsin B, or apoptosis-inducing factor function significantly suppressed cell killing. In parallel, OSU caused PERK-dependent increases in 70-kDa heat shock protein (HSP70) expression and decreases in 90-kDa heat shock protein (HSP90) and Grp78/BiP expression. Changes in HSP70 expression were post-transcriptional. Knock-down or small-molecule inhibition of HSP70 expression enhanced OSU toxicity, and overexpression of HSP70 suppressed OSU-induced low pH vesicle formation and lethality. Our data demonstrate that OSU-03012 causes cell killing that is dependent on PERK-induced activation of multiple toxic proteases. OSU-03012 also increased expression of HSP70 in a PERK-dependent fashion, providing support for the contention that OSU-03012-induced PERK signaling promotes both cell survival and cell death processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182481      PMCID: PMC2674576          DOI: 10.1124/mol.107.042697

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  51 in total

Review 1.  A trip to the ER: coping with stress.

Authors:  D Thomas Rutkowski; Randal J Kaufman
Journal:  Trends Cell Biol       Date:  2004-01       Impact factor: 20.808

2.  Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes.

Authors:  Salamatu S Mambula; Stuart K Calderwood
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 3.  Molecular mechanism and regulation of autophagy.

Authors:  Ya-Ping Yang; Zhong-Qin Liang; Zhen-Lun Gu; Zheng-Hong Qin
Journal:  Acta Pharmacol Sin       Date:  2005-12       Impact factor: 6.150

4.  Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cells.

Authors:  Robert McKinstry; Liang Qiao; Adly Yacoub; Yun Dai; Roy Decker; Shawn Holt; Michael P Hagan; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2002 May-Jun       Impact factor: 4.742

5.  Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.

Authors:  Steffan T Nawrocki; Jennifer S Carew; Kenneth Dunner; Lawrence H Boise; Paul J Chiao; Peng Huang; James L Abbruzzese; David J McConkey
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

6.  A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism.

Authors:  Amy J Johnson; Lisa L Smith; Jiuxiang Zhu; Nyla A Heerema; Sara Jefferson; Andrew Mone; Michael Grever; Ching-Shih Chen; John C Byrd
Journal:  Blood       Date:  2004-09-28       Impact factor: 22.113

7.  OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.

Authors:  Shuhong Zhang; Attaya Suvannasankha; Colin D Crean; Valerie L White; Amy Johnson; Ching-Shih Chen; Sherif S Farag
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

Review 8.  Autophagy and other vacuolar protein degradation mechanisms.

Authors:  P O Seglen; P Bohley
Journal:  Experientia       Date:  1992-02-15

9.  The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress.

Authors:  Mohamed Rahmani; Eric Maynard Davis; Timothy Ryan Crabtree; Joseph Reza Habibi; Tri K Nguyen; Paul Dent; Steven Grant
Journal:  Mol Cell Biol       Date:  2007-06-04       Impact factor: 4.272

10.  The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice.

Authors:  Frank Michael Klenke; Martha-Maria Gebhard; Volker Ewerbeck; Amir Abdollahi; Peter E Huber; Axel Sckell
Journal:  BMC Cancer       Date:  2006-01-12       Impact factor: 4.430

View more
  49 in total

1.  17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species.

Authors:  Teneille Walker; Clint Mitchell; Margaret A Park; Adly Yacoub; Mohamed Rahmani; Dieter Häussinger; Roland Reinehr; Christina Voelkel-Johnson; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

Review 2.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

3.  Regulatory coordination between two major intracellular homeostatic systems: heat shock response and autophagy.

Authors:  Karol Dokladny; Micah Nathaniel Zuhl; Michael Mandell; Dhruva Bhattacharya; Suzanne Schneider; Vojo Deretic; Pope Lloyd Moseley
Journal:  J Biol Chem       Date:  2013-04-10       Impact factor: 5.157

4.  Obatoclax and lapatinib interact to induce toxic autophagy through NOXA.

Authors:  Yong Tang; Hossein A Hamed; Nichola Cruickshanks; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2012-01-04       Impact factor: 4.436

Review 5.  Unfolded Protein Response as a Therapeutic Target in Cardiovascular Disease.

Authors:  Guangyu Zhang; Xiaoding Wang; Thomas G Gillette; Yingfeng Deng; Zhao V Wang
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

6.  HSPA5/Dna K may be a useful target for human disease therapies.

Authors:  Laurence Booth; Jane L Roberts; Paul Dent
Journal:  DNA Cell Biol       Date:  2015-03       Impact factor: 3.311

7.  Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death.

Authors:  Clint Mitchell; Hossein A Hamed; Nichola Cruickshanks; Yong Tang; M Danielle Bareford; Nissan Hubbard; Gary Tye; Adly Yacoub; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

8.  Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation.

Authors:  Margaret A Park; Guo Zhang; Aditi Pandya Martin; Hossein Hamed; Clint Mitchell; Philip B Hylemon; Martin Graf; Mohamed Rahmani; Kevin Ryan; Xiang Liu; Sarah Spiegel; James Norris; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2008-10-12       Impact factor: 4.742

9.  Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation.

Authors:  Guo Zhang; Margaret A Park; Clint Mitchell; Hossein Hamed; Mohamed Rahmani; Aditi Pandya Martin; David T Curiel; Adly Yacoub; Martin Graf; Ray Lee; John D Roberts; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

10.  Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent.

Authors:  Hao-Chieh Chiu; Shilpa Soni; Samuel K Kulp; Heather Curry; Dasheng Wang; John S Gunn; Larry S Schlesinger; Ching-Shih Chen
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.